Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Oct;116(4):2251–2257. doi: 10.1111/j.1476-5381.1995.tb15061.x

Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse.

M Perretti 1, C Szabó 1, C Thiemermann 1
PMCID: PMC1908976  PMID: 8564256

Abstract

1. The effect of systemic treatment of mice with murine recombinant interleukin-4 (IL-4) or interleukin-10 (IL-10) on neutrophil infiltration into a specific tissue site and nitric oxide (NO) production from peritoneal macrophages was investigated. 2. Intravenously (i.v.) administered IL-4 (0.01-10 micrograms per mouse, approximately 0.3-300 micrograms kg-1, i.v.) and IL-10 (0.01-1 micrograms per mouse, approximately 0.3-30 micrograms kg-1, i.v.) dose-dependently inhibited neutrophil accumulation into a 6-day-old murine air-pouch induced by local application of interleukin-1 beta (IL-1 beta, 5 ng), with approximate ED50s of 0.35 and 0.90 micrograms, respectively. Neither IL-4 (1 micrograms, 30 micrograms kg-1, i.v.) nor IL-10 (1 micrograms, 30 micrograms kg-1, i.v.) prevented leucocyte accumulation in the mouse air-pouches when interleukin-8 (IL-8, 1 micrograms) was used as chemoattractant. Similarly, neither cytokine had any effect on the in vitro up-regulation of CD11b antigen on the surface of murine circulating neutrophils. 3. Treatment of mice with lipopolysaccharide (LPS, 0.3 mg kg-1, i.p.) caused an increase in the formation of NO (measured as nitrite accumulation) in the supernatant of peritoneal macrophages ex vivo. Pretreatment of mice with IL-4 (0.01-1 micrograms i.v., 20 min before LPS), but not with IL-10 (1 micrograms i.v., 20 min before LPS), caused a dose-dependent reduction in this LPS-stimulated formation of nitrite by peritoneal macrophages ex vivo. 4. Activation of murine macrophages with LPS (1 microgram ml-1 for 24 h) in vitro caused a significant increase in nitrite release in the supernatant of these cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
2251

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bogdan C., Vodovotz Y., Paik J., Xie Q. W., Nathan C. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J Leukoc Biol. 1994 Feb;55(2):227–233. doi: 10.1002/jlb.55.2.227. [DOI] [PubMed] [Google Scholar]
  2. Broaddus V. C., Boylan A. M., Hoeffel J. M., Kim K. J., Sadick M., Chuntharapai A., Hébert C. A. Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol. 1994 Mar 15;152(6):2960–2967. [PubMed] [Google Scholar]
  3. Cassatella M. A., Meda L., Bonora S., Ceska M., Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med. 1993 Dec 1;178(6):2207–2211. doi: 10.1084/jem.178.6.2207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cassatella M. A., Meda L., Gasperini S., Calzetti F., Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med. 1994 May 1;179(5):1695–1699. doi: 10.1084/jem.179.5.1695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chesrown S. E., Monnier J., Visner G., Nick H. S. Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem Biophys Res Commun. 1994 Apr 15;200(1):126–134. doi: 10.1006/bbrc.1994.1424. [DOI] [PubMed] [Google Scholar]
  6. Corradin S. B., Fasel N., Buchmüller-Rouiller Y., Ransijn A., Smith J., Mauël J. Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10. Eur J Immunol. 1993 Aug;23(8):2045–2048. doi: 10.1002/eji.1830230851. [DOI] [PubMed] [Google Scholar]
  7. Cunha F. Q., Assreuy J., Moss D. W., Rees D., Leal L. M., Moncada S., Carrier M., O'Donnell C. A., Liew F. Y. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology. 1994 Feb;81(2):211–215. [PMC free article] [PubMed] [Google Scholar]
  8. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  9. Donnelly R. P., Crofford L. J., Freeman S. L., Buras J., Remmers E., Wilder R. L., Fenton M. J. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. J Immunol. 1993 Nov 15;151(10):5603–5612. [PubMed] [Google Scholar]
  10. Harada A., Sekido N., Kuno K., Akiyama M., Kasahara T., Nakanishi I., Mukaida N., Matsushima K. Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin. Int Immunol. 1993 Jun;5(6):681–690. doi: 10.1093/intimm/5.6.681. [DOI] [PubMed] [Google Scholar]
  11. Harris J. G., Flower R. J., Perretti M. Alteration of neutrophil trafficking by a lipocortin 1 N-terminus peptide. Eur J Pharmacol. 1995 Jun 12;279(2-3):149–157. doi: 10.1016/0014-2999(95)00145-b. [DOI] [PubMed] [Google Scholar]
  12. Hart P. H., Vitti G. F., Burgess D. R., Whitty G. A., Piccoli D. S., Hamilton J. A. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci U S A. 1989 May;86(10):3803–3807. doi: 10.1073/pnas.86.10.3803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hechtman D. H., Cybulsky M. I., Fuchs H. J., Baker J. B., Gimbrone M. A., Jr Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J Immunol. 1991 Aug 1;147(3):883–892. [PubMed] [Google Scholar]
  14. Huber A. R., Kunkel S. L., Todd R. F., 3rd, Weiss S. J. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science. 1991 Oct 4;254(5028):99–102. doi: 10.1126/science.1718038. [DOI] [PubMed] [Google Scholar]
  15. Katsikis P. D., Chu C. Q., Brennan F. M., Maini R. N., Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med. 1994 May 1;179(5):1517–1527. doi: 10.1084/jem.179.5.1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kubes P., Kanwar S., Niu X. F., Gaboury J. P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 1993 Oct;7(13):1293–1299. doi: 10.1096/fasebj.7.13.8405815. [DOI] [PubMed] [Google Scholar]
  17. Kurose I., Kubes P., Wolf R., Anderson D. C., Paulson J., Miyasaka M., Granger D. N. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res. 1993 Jul;73(1):164–171. doi: 10.1161/01.res.73.1.164. [DOI] [PubMed] [Google Scholar]
  18. Le Bouteiller P. P., Mishal Z., Lemonnier F. A., Kourilsky F. M. Quantification by flow cytofluorimetry of HLA class I molecules at the surface of murine cells transformed by cloned HLA genes. J Immunol Methods. 1983 Jul 29;61(3):301–315. doi: 10.1016/0022-1759(83)90224-7. [DOI] [PubMed] [Google Scholar]
  19. Ley K., Baker J. B., Cybulsky M. I., Gimbrone M. A., Jr, Luscinskas F. W. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol. 1993 Dec 1;151(11):6347–6357. [PubMed] [Google Scholar]
  20. Lin G., Pearson A. E., Scamurra R. W., Zhou Y., Baarsch M. J., Weiss D. J., Murtaugh M. P. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J Biol Chem. 1994 Jan 7;269(1):77–85. [PubMed] [Google Scholar]
  21. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  22. Mulligan M. S., Jones M. L., Vaporciyan A. A., Howard M. C., Ward P. A. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol. 1993 Nov 15;151(10):5666–5674. [PubMed] [Google Scholar]
  23. Olofsson A. M., Arfors K. E., Ramezani L., Wolitzky B. A., Butcher E. C., von Andrian U. H. E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules. Blood. 1994 Oct 15;84(8):2749–2758. [PubMed] [Google Scholar]
  24. Paul W. E. Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions. FASEB J. 1987 Dec;1(6):456–461. doi: 10.1096/fasebj.1.6.3315808. [DOI] [PubMed] [Google Scholar]
  25. Perretti M., Ahluwalia A., Flower R. J., Manzini S. Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology. 1993 Sep;80(1):73–77. [PMC free article] [PubMed] [Google Scholar]
  26. Perretti M., Ahluwalia A., Harris J. G., Goulding N. J., Flower R. J. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol. 1993 Oct 15;151(8):4306–4314. [PubMed] [Google Scholar]
  27. Perretti M., Flower R. J. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol. 1993 Feb 1;150(3):992–999. [PubMed] [Google Scholar]
  28. Perretti M., Harris J. G., Flower R. J. A role for endogenous histamine in interleukin-8-induced neutrophil infiltration into mouse air-pouch: investigation of the modulatory action of systemic and local dexamethasone. Br J Pharmacol. 1994 Jul;112(3):801–808. doi: 10.1111/j.1476-5381.1994.tb13150.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ralph P., Nakoinz I., Sampson-Johannes A., Fong S., Lowe D., Min H. Y., Lin L. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol. 1992 Feb 1;148(3):808–814. [PubMed] [Google Scholar]
  30. Roberts P. J., Pizzey A. R., Khwaja A., Carver J. E., Mire-Sluis A. R., Linch D. C. The effects of interleukin-8 on neutrophil fMetLeuPhe receptors, CD11b expression and metabolic activity, in comparison and combination with other cytokines. Br J Haematol. 1993 Aug;84(4):586–594. doi: 10.1111/j.1365-2141.1993.tb03132.x. [DOI] [PubMed] [Google Scholar]
  31. Rosen H., Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J Exp Med. 1987 Dec 1;166(6):1685–1701. doi: 10.1084/jem.166.6.1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol. 1994 Jun;24(6):1434–1440. doi: 10.1002/eji.1830240629. [DOI] [PubMed] [Google Scholar]
  33. Schneemann M., Schoedon G., Frei K., Schaffner A. Immunovascular communication: activation and deactivation of murine endothelial cell nitric oxide synthase by cytokines. Immunol Lett. 1993 Feb;35(2):159–162. doi: 10.1016/0165-2478(93)90085-g. [DOI] [PubMed] [Google Scholar]
  34. Szabó C., Wu C. C., Mitchell J. A., Gross S. S., Thiemermann C., Vane J. R. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res. 1993 Dec;73(6):991–999. doi: 10.1161/01.res.73.6.991. [DOI] [PubMed] [Google Scholar]
  35. Thiemermann C. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol. 1994;28:45–79. doi: 10.1016/s1054-3589(08)60493-7. [DOI] [PubMed] [Google Scholar]
  36. Vane J. R., Mitchell J. A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughby D. A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2046–2050. doi: 10.1073/pnas.91.6.2046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vannier E., Miller L. C., Dinarello C. A. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4076–4080. doi: 10.1073/pnas.89.9.4076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wertheim W. A., Kunkel S. L., Standiford T. J., Burdick M. D., Becker F. S., Wilke C. A., Gilbert A. R., Strieter R. M. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol. 1993 Aug 15;151(4):2166–2175. [PubMed] [Google Scholar]
  39. Wong H. L., Costa G. L., Lotze M. T., Wahl S. M. Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J Exp Med. 1993 Mar 1;177(3):775–781. doi: 10.1084/jem.177.3.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zlotnik A., Moore K. W. Interleukin 10. Cytokine. 1991 Sep;3(5):366–371. doi: 10.1016/1043-4666(91)90039-g. [DOI] [PubMed] [Google Scholar]
  41. de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., de Vries J. E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991 Nov 1;174(5):1209–1220. doi: 10.1084/jem.174.5.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES